Hamilton Insurance Group, Ltd.
Business
Hamilton Insurance Group, Ltd. is a global specialty insurance and reinsurance company that underwrites and assumes risk across commercial, casualty and specialty lines. It offers property, casualty and specialty insurance and reinsurance products, including U.S. excess & surplus (E&S) coverage, high-excess Bermuda market insurance, professional and financial lines, marine/energy, cyber, A&H, political risk and treaty facultative reinsurance. The business operates three principal underwriting platforms—Hamilton Global Specialty, Hamilton Select and Hamilton Re—reported through International and Bermuda segments. Distribution and markets include Lloyd’s Syndicate 4000, a Dublin insurer, Bermuda operations and U.S. E&S access via wholesale and surplus lines brokers, major global brokers, MGAs/MGUs and reinsurance brokers.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-11-30 |
|---|---|---|---|---|---|---|
| Gross premiums written | 2,923 | 2,423 | 1,951 | 1,647 | 1,447 | |
| Reinsurance premiums ceded | −636 | −501 | −471 | −425 | −361 | |
| Net premiums written | 2,288 | 1,921 | 1,480 | 1,222 | 1,085 | |
| Net change in unearned premiums | −178 | −186 | −162 | −78 | −143 | |
| Net premiums earned | 2,110 | 1,735 | 1,319 | 1,144 | 943 | |
| Net realized and unrealized gains (losses) on investments | 687 | 511 | 210 | 93 | 352 | |
| Net investment income (loss) | 88 | 63 | 30 | −21 | −43 | |
| Total net realized and unrealized gains (losses) on investments and net investment income (loss) | 775 | 575 | 240 | 72 | 309 | |
| Other income (loss) | 27 | 24 | 19 | 11 | 21 | |
| Net foreign exchange gains (losses) | −6 | −3 | −6 | 6 | 6 | |
| Total revenues | 2,906 | 2,330 | 1,571 | 1,233 | 1,334 | |
| Losses and loss adjustment expenses | 1,259 | 1,010 | 715 | 758 | 641 | |
| Acquisition costs | 507 | 389 | 309 | 271 | 229 | |
| General and administrative expenses | 279 | 271 | 260 | 178 | 172 | |
| Amortization of intangible assets | 16 | 16 | 11 | 13 | 13 | |
| Interest expense | 20 | 23 | 21 | 16 | 15 | |
| Total expenses | 2,081 | 1,708 | 1,316 | 1,260 | 1,071 | |
| Income (loss) before income tax | 825 | 622 | 255 | −27 | 262 | |
| Income tax expense (benefit) | −15 | 8 | −25 | 3 | 12 | |
| Net income (loss) | 840 | 613 | 280 | −30 | 250 | |
| Net income (loss) attributable to non-controlling interest | 263 | 213 | 22 | 68 | 62 | |
| Net income (loss) and other comprehensive income (loss) attributable to common shareholders | 577 | 400 | 259 | −98 | 188 | |
| Basic income (loss) per share attributable to common shareholders | 5.75 | 3.81 | 2.47 | −0.95 | 1.83 | |
| Diluted income (loss) per share attributable to common shareholders | 5.55 | 3.67 | 2.44 | −0.95 | 1.82 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Investments, at fair value | 3,439 | 2,875 | 2,260 | 1,546 | — | |
| Investments in Two Sigma Funds, at fair value (cost 2025: $1,355,563; 2024: $805,623) | 1,588 | 939 | 851 | 741 | — | |
| Total investments | 5,027 | 3,814 | 3,112 | 2,286 | — | |
| Cash and cash equivalents | 1,100 | 997 | 795 | 1,100 | — | |
| Restricted cash and cash equivalents | 110 | 104 | 106 | 131 | — | |
| Premiums receivable | 940 | 772 | 658 | 523 | — | |
| Paid losses recoverable | 94 | 134 | 145 | 91 | — | |
| Deferred acquisition costs | 257 | 209 | 157 | 115 | — | |
| Unpaid losses and loss adjustment expenses recoverable | 1,400 | 1,200 | 1,161 | 1,178 | 1,113 | |
| Receivables for investments sold | 58 | 74 | 42 | 371,000 | — | |
| Prepaid reinsurance | 296 | 219 | 194 | 164 | — | |
| Intangible assets | 87 | 93 | 91 | 87 | — | |
| Other assets | 265 | 209 | 210 | 167 | — | |
| Total assets | 9,572 | 7,796 | 6,671 | 5,819 | — | |
| Reserve for losses and loss adjustment expenses | 4,415 | 3,532 | 3,030 | 2,856 | 2,415 | |
| Unearned premiums | 1,377 | 1,122 | 911 | 718 | — | |
| Reinsurance balances payable | 296 | 261 | 272 | 244 | — | |
| Payable for investments purchased | 210 | 115 | 67 | 48 | — | |
| Term loan, net of issuance costs | 150 | 150 | 150 | 150 | — | |
| Accounts payable and accrued expenses | 177 | 185 | 187 | 138 | — | |
| Payables to related parties | 123 | 100 | 6 | 20,000 | — | |
| Total liabilities | 6,749 | 5,467 | 4,623 | 4,155 | — | |
| Non-controlling interest TS Hamilton Fund | 172,000 | 128,000 | 133,000 | 119,000 | — | |
| Common shares: | 990,000 | 1 | 1 | 1 | — | |
| Additional paid-in capital | 1,135 | 1,164 | 1,250 | 1,120 | — | |
| Accumulated other comprehensive loss | −4 | −4 | −4 | −4 | — | |
| Retained earnings | 1,691 | 1,169 | 801 | 547 | — | |
| Total shareholders' equity | 2,822 | 2,329 | 2,048 | 1,664 | 1,753 | |
| Total liabilities, non-controlling interest, and shareholders equity | 9,572 | 7,796 | 6,671 | 5,819 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-11-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 16 | 16 | 12 | 15 | 14 | |
| Share compensation expense | 29 | 30 | 44 | 11 | 9 | |
| Net realized (gains) losses on investments | −517 | −468 | −85 | −259 | — | |
| Change in net unrealized (gains) losses on investments | −170 | −43 | −125 | 165 | −74 | |
| Other items | −29 | 4 | −7 | 12 | 7 | |
| Premiums receivable | −168 | −113 | −136 | −60 | −13 | |
| Paid losses recoverable | 41 | 11 | −55 | −11 | −48 | |
| Deferred acquisition costs | −48 | −52 | −42 | −16 | −41 | |
| Prepaid reinsurance | −77 | −25 | −30 | −12 | 9 | |
| Unpaid losses and loss adjustment expenses recoverable | −205 | −10 | 17 | −65 | −42 | |
| Other assets | −57 | 1 | −43 | −42 | −15 | |
| Reserve for losses and loss adjustment expenses | 883 | 502 | 174 | 441 | 324 | |
| Unearned premiums | 255 | 211 | 193 | 97 | 141 | |
| Reinsurance balances payable | 35 | −11 | 28 | −42 | −24 | |
| Accounts payable and accrued expenses and other | 15 | 92 | 55 | −36 | 61 | |
| Net cash provided by (used in) operating activities | 842 | 759 | 283 | 191 | 227 | |
| Proceeds from redemptions from Two Sigma Funds | 2,654 | 2,874 | 2,592 | 2,592 | 2,114 | |
| Contributions to Two Sigma Funds | −2,715 | −2,481 | −2,555 | −2,465 | −1,870 | |
| Purchases of fixed maturity investments | −2,485 | −1,930 | −1,222 | −705 | −656 | |
| Proceeds from sales, redemptions and maturity of fixed maturity investments | 1,714 | 1,381 | 689 | 421 | 347 | |
| Purchases of short-term investments | −1,100 | −1,832 | −1,506 | −1,552 | −2,036 | |
| Proceeds from sales of short-term investments | 1,417 | 1,805 | 1,389 | 1,843 | 2,164 | |
| Change in receivables for investments sold | 16 | −32 | −42 | — | — | |
| Change in payables for investments purchased | 94 | 49 | 19 | — | — | |
| Other | −9 | −19 | −16 | −14 | −16 | |
| Net cash provided by (used in) investing activities | −414 | −184 | −652 | 133 | 138 | |
| Issuance of common shares | 25,000 | 26,000 | 73,000 | 7,000 | 5,000 | |
| Repurchases of common shares | −113 | −150 | −2 | −2 | −7 | |
| Contribution of additional paid-in capital | −26,000 | 370,000 | 83 | 308,000 | 1 | |
| Term loan, net of issuance costs | −311,000 | 0 | 0 | −345,000 | 0 | |
| Withdrawal of non-controlling interest | −263 | −213 | −22 | −68 | −62 | |
| Net cash provided by (used in) financing activities | −376 | −363 | 59 | −70 | −68 | |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | 19 | −12 | 4 | −11 | −2 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | 71 | 200 | −306 | 243 | 295 | |
| Net income taxes paid | 16 | 11 | 4 | 10 | 12 | |
| Interest paid | 22 | 22 | 22 | 16 | 12 |